You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 15, Issue 23

December-1 2023 - 213 articles

Cover Story: Lung cancer is the leading cause of cancer death worldwide; small-cell lung cancer (SCLC) and large-cell neuroendocrine carcinoma (LCNEC) are even more clinically malignant. These neuroendocrine carcinomas (NECs) have different treatment strategies than non-small cell lung cancer, and rapid and correct diagnosis improves the patients’ prognosis. However, in routine practice, we often encounter cases of NEC that are poorly stained with the existing markers. We investigated the utility of Musashi-1 as a novel immunohistochemical marker in lung resection specimens of SCLC and LCNEC. We found that Musashi-1 was expressed in all the SCLC cases and in 90% of the LCNEC cases. These findings demonstrate that Musashi-1 can be a novel immunohistochemical marker for lung NEC. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (213)

  • Review
  • Open Access
9 Citations
5,213 Views
17 Pages

Unraveling the Intricacies of CD73/Adenosine Signaling: The Pulmonary Immune and Stromal Microenvironment in Lung Cancer

  • Maria Saigí,
  • Oscar Mesía-Carbonell,
  • David A. Barbie and
  • Raquel Guillamat-Prats

4 December 2023

CD73 and adenosine have gained prominence in lung cancer research. The NT5E gene encodes CD73, known as an ectonucleotidase, which plays a crucial role within tumor cells, with immune-suppressive properties. Beyond cancer, CD73 exerts an influence on...

  • Review
  • Open Access
11 Citations
5,129 Views
24 Pages

Predictive Factors for Chemoradiation-Induced Oral Mucositis and Dysphagia in Head and Neck Cancer: A Scoping Review

  • Alexander J. Nicol,
  • Jerry C. F. Ching,
  • Victor C. W. Tam,
  • Kelvin C. K. Liu,
  • Vincent W. S. Leung,
  • Jing Cai and
  • Shara W. Y. Lee

4 December 2023

Despite advances in head and neck cancer treatment, virtually all patients experience chemoradiation-induced toxicities. Oral mucositis (OM) and dysphagia are among the most prevalent and have a systemic impact on patients, hampering treatment outcom...

  • Article
  • Open Access
11 Citations
3,617 Views
18 Pages

Identification of SPP1 as a Prognostic Biomarker and Immune Cells Modulator in Urothelial Bladder Cancer: A Bioinformatics Analysis

  • Taoufik Nedjadi,
  • Mohamed Eldigire Ahmed,
  • Hifzur R. Ansari,
  • Sihem Aouabdi and
  • Jaudah Al-Maghrabi

4 December 2023

Secreted phosphoprotein-1 (SPP1) expression is differentially altered in many malignancies and could serve as a potential prognostic biomarker. Recent findings indicated that SPP1 possesses a broader role in bladder cancer (BC) pathogenesis than prev...

  • Article
  • Open Access
2 Citations
2,019 Views
15 Pages

Analysis of Health-Related Quality of Life Reporting in Phase III RCTs of Advanced Genitourinary Tumors

  • Fabrizio Di Costanzo,
  • Fabiana Napolitano,
  • Fabio Salomone,
  • Anna Rita Amato,
  • Gennaro Alberico,
  • Fortuna Migliaccio,
  • Giovanna Pecoraro,
  • Annachiara Marra,
  • Felice Crocetto and
  • Antonio Ruffo
  • + 7 authors

4 December 2023

Background: As recommended in the European Society for Medical Oncology (ESMO) guidelines, assessment of health-related quality of life (HRQoL) should be a relevant endpoint in randomized controlled trials (RCTs) testing new anticancer therapies. How...

  • Article
  • Open Access
6 Citations
3,356 Views
18 Pages

Preoperative Intensified Chemoradiation with Intensity-Modulated Radiotherapy and Simultaneous Integrated Boost Combined with Capecitabine in Locally Advanced Rectal Cancer: Long-Term Outcomes of a Real-Life Multicenter Study

  • Marco Lupattelli,
  • Elisa Palazzari,
  • Jerry Polesel,
  • Giuditta Chiloiro,
  • Ilaria Angelicone,
  • Valeria Panni,
  • Luciana Caravatta,
  • Saide Di Biase,
  • Gabriella Macchia and
  • Rita Marina Niespolo
  • + 12 authors

4 December 2023

Background: Despite the feasibility and promising activity data on intensity-modulated RT and simultaneous integrated boost (IMRT-SIB) dose escalation in preoperative chemoradiation (CRT) for locally advanced rectal cancer (LARC), few data are curren...

  • Systematic Review
  • Open Access
22 Citations
6,307 Views
19 Pages

3 December 2023

(1) Background: The aim of our research was to systematically review papers specifically focused on the hepatocellular carcinoma (HCC) diagnostic performance of DL methods based on medical images. (2) Materials: To identify related studies, a compreh...

  • Article
  • Open Access
10 Citations
5,664 Views
11 Pages

Comparing Prognosis for BRCA1, BRCA2, and Non-BRCA Breast Cancer

  • Pedro Antunes Meireles,
  • Sofia Fragoso,
  • Teresa Duarte,
  • Sidónia Santos,
  • Catarina Bexiga,
  • Priscila Nejo,
  • Ana Luís,
  • Beatriz Mira,
  • Isália Miguel and
  • Paula Rodrigues
  • + 1 author

3 December 2023

Background: Germline pathogenic variants (PV) in BRCA1 and BRCA2 genes, which account for 20% of familial breast cancer (BC) cases, are highly penetrant and are associated with Hereditary Breast/Ovarian Cancer Syndrome. Previous studies, mostly inclu...

  • Article
  • Open Access
1 Citations
3,229 Views
10 Pages

Clinical Profile of Tuberculum Sellae Meningiomas Based on Scoring System: An Institutional Experience in Indonesia

  • Renindra Ananda Aman,
  • Risayogi W. A. H. Sitorus,
  • Muhamad Aulia Rahman,
  • Fabianto Santoso and
  • Ramadhan Kurniawan

3 December 2023

Tuberculum sellae meningioma (TSM) is a challenging tumor that grows close to several crucial structures, such as the optic nerve, arteries, and pituitary. Surgical treatment is currently evolving from a transcranial microsurgical resection to a tran...

  • Article
  • Open Access
10 Citations
4,268 Views
14 Pages

3 December 2023

Background: This study aimed to assess the relative efficacy of modern radiotherapy strategies in patients with newly diagnosed glioblastoma. Method: A comprehensive literature review was conducted through MEDLINE, Embase and the Cochrane Central Reg...

  • Article
  • Open Access
7 Citations
2,785 Views
14 Pages

Gold Nanoparticles Enhance the Tumor Growth-Suppressing Effects of Cetuximab and Radiotherapy in Head and Neck Cancer In Vitro and In Vivo

  • Takumi Sato,
  • Yasumasa Kakei,
  • Takumi Hasegawa,
  • Masahiko Kashin,
  • Shun Teraoka,
  • Akinobu Yamaguchi,
  • Ryohei Sasaki and
  • Masaya Akashi

3 December 2023

Introduction: Head and neck squamous cell carcinoma (HNSCC) treatment includes surgery, radiotherapy, and immunotherapy with the aim of eradicating cancer cells without affecting normal tissues. HNSCC expresses epidermal growth factor receptor (EGFR)...

of 22

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694